(HealthDay News) — For patients with hip fracture, delayed admission is associated with increased mortality risk, according to a study published online in Emergency Medicine Journal.

1 in 5 asymptomatic individuals were antigen-positive versus half of those with ongoing cardiopulmonary, musculoskeletal, and neurologic symptoms ...

The FDA has granted Orphan Drug designation to LQT-1213, a serum glucocorticoid regulated kinase 1 inhibitor, for long QT syndrome.

Gilead is withdrawing the accelerated approval of Trodelvy (sacituzumab govitecan-hziy) for metastatic urothelial cancer.

Patients not waitlisted for kidney transplant received breast or prostate cancer screening at lower-than-expected rates, including those with good life expectancy. Breast and prostate cancer ...

Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) warranting optimized management.

(HealthDay News) — There are no significant differences in all-cause or cardiovascular mortality with the prescription of dialysate calcium 1.50 versus 1.25 mmol/L for patients undergoing hemodialysis ...

(HealthDay News) — Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the US Food and Drug Administration revisits its Oct. 2 decision to remove the ...

Kidney transplant between donors and recipients with HIV is successful, research shows, which may help addresses the organ ...

Joseph M. Unger, PhD, from the Fred Hutchinson Cancer Center in Seattle, and colleagues evaluated cancer trial enrollment patterns from 2008 to 2022 using ClinicalTrials.gov data to estimate the ratio ...

Local radiation therapy appears beneficial for men with bone metastatic hormone-sensitive prostate cancer (mHSPC).

The FDA granted Priority Review to gepotidacin for the treatment of female adults and adolescents with uncomplicated UTI.